Tilray Brands, Inc.
corporate_fare Company Profile
Tilray Brands, Inc. (NASDAQ:TLRY) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 26 items for TLRY at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-14, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 8 rated 8 or above. Recent SEC coverage for TLRY spans 8-K, 10-K, 10-Q.
Recent high-impact activity:
- Tilray Retires $12M of Convertible Debt for 2.84M Shares in Fourth Swap
- Tilray Swaps $6M of Convertible Debt for 1.38M Shares, Extending a Pattern of Dilution
- Tilray Posts Record FY2026 Revenue of $915.5M and Sets FY2027 Adjusted EBITDA Guidance at $68M–$75M
- Tilray Q4 Revenue Jumps 25% to $282M, Adjusted EPS Hits $0.05
- Tilray Guides FY27 Adjusted EBITDA to $68M-$75M, Signaling Profit Growth
Financial Snapshot
Short Interest & Short Volume
5.22 days to coverFINRA reported short interest of 19,418,606 shares in TLRY as of the September 15, 2026 settlement, a 7.5% increase from the prior period — about 5.2 days to cover at its recent average daily volume. On October 2, 2026, 37.8% of TLRY volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for TLRY, detected from its recent SEC filings · based on capital-structure filings through 2026-09-14.
Fourth Debt-for-Equity Exchange · Cumulative Dilution from Exchanges
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →